Loading

Get in touch: we're here to assist with your inquiries and support your needs.

Astra Industrial Group announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months )

Element List

Current Quarter

Similar quarter for previous year

%Change

Previous Quarter

% Change

Sales/Revenue

790,909,047

833,728,170

-5.135

791,827,797

-0.116

Gross Profit (Loss)

385,259,335

372,598,003

3.398

368,859,731

4.446

Operational Profit (Loss)

192,085,715

189,301,115

1.47

119,688,569

60.487

Net Profit (Loss) Attributable to Shareholders of the Issuer

173,138,809

171,871,096

0.737

152,574,252

13.478

Total Comprehensive Income Attributable to Shareholders of the Issuer

172,515,689

176,723,126

-2.38

156,953,969

9.914

All figures are in (Actual) Saudi Arabia, Riyals

Element List

Current Period

Similar period for previous year

%Change

Total Shareholders Equity (after Deducting Minority Equity)

3,134,506,371

2,700,529,204

16.07

Profit (Loss) per Share

2.16

2.15

All figures are in (Actual) Saudi Arabia, Riyals

Element List

Amount

Percentage of the capital (%)

Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value

–

–

All figures are in (Actual) Saudi Arabia, Riyals

Element List

Explanation

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is

Revenue decreases in general due to:
Decrease in revenue in the following segments:
a) Steel Industry
b) Specialty chemical.

While noting that there is slight increase in revenue in pharmaceuticals segment.

The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is

Net profit Increases in general due to:
1. Increase in Gross Profit in the following segments:
a) Pharmaceuticals
b) Steel Industry
2. Decrease in finance costs mainly in the following segments:
a) Specialty Chemical
b) Pharmaceuticals.
While noting that there is decrease in other income, net in other segment.

The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is

Sales decrease in general due to:
Decrease in sales in steel segment.
While noting that there is increase in sales in the pharmaceuticals segment.

The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is

Net profit Increases in general due to:
1. Increase Gross Profit in Profit in the following segments:
a. Pharmaceuticals
b. Specialty chemical
While noting that there is decrease in Gross Profit in Steel industries.
2. Decrease in General and administrative expenses in following sectors:
a) Steel industries
b) Specialty chemical
3. Decrease in Provision for impairment of financial assets expenses in following sectors:
a) Steel industries
b) Specialty chemical
While noting that there is decrease in share in profit from unconsolidated subsidiary.

Statement of the type of external auditor’s report

Unmodified conclusion

Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)

NA

Reclassification of Comparison Items

Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.

Additional Information

Net Shareholders’ Equity at the end of the period was SR 3,133,945,566/- compared to SR 2,707,857,633 /- at the end of the similar period last year with an increase of 16%.